Details for New Drug Application (NDA): 021807

✉ Email this page to a colleague

NDA 021807 describes SOLTAMOX, which is a drug marketed by Mayne Pharma Commrcl and is included in one NDA. It is available from one supplier. Additional details are available on the SOLTAMOX profile page.

The generic ingredient in SOLTAMOX is tamoxifen citrate. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.

Summary for 021807

Tradename:	SOLTAMOX
Applicant:	Mayne Pharma Commrcl
Ingredient:	tamoxifen citrate
Patents:	0

Pharmacology for NDA: 021807

Mechanism of Action	Selective Estrogen Receptor Modulators

Medical Subject Heading (MeSH) Categories for 021807

Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Estrogen Antagonists
Selective Estrogen Receptor Modulators

Suppliers and Packaging for NDA: 021807

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SOLTAMOX	tamoxifen citrate	SOLUTION;ORAL	021807	NDA	Mayne Pharma	51862-682	51862-682-00	1 CONTAINER in 1 CARTON (51862-682-00) / 150 mL in 1 CONTAINER
SOLTAMOX	tamoxifen citrate	SOLUTION;ORAL	021807	NDA	Mayne Pharma	51862-682	51862-682-01	1 CONTAINER in 1 CARTON (51862-682-01) / 150 mL in 1 CONTAINER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;ORAL			Strength	EQ 20MG BASE/10ML
Approval Date:	Oct 29, 2005	TE:		RLD:	Yes

Expired US Patents for NDA 021807

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mayne Pharma Commrcl	SOLTAMOX	tamoxifen citrate	SOLUTION;ORAL	021807-001	Oct 29, 2005	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.